○Dieter Kunz (Department of Physiology, Charite - Universitymedicine Berlin, Germany)
Session information
Symposium
[S-08] Symposium 08 RBD as a harbinger of synucleinopathy: update
Wed. May 19, 2021 2:15 PM - 4:15 PM Room 05 (ICC Kyoto 2F Room B-1)
Chair:Miyamoto Tomoyuki(Department of neurology, Dokkyo Medical University Saitama Medical Center),Suzuki Keisuke(Department of Neurology, Dokkyo Medical University)
REM sleep behavior disorder (RBD) is a parasomnia, characterized by dream-enacting behavior during REM sleep and the polysomnographic findings of REM sleep without atonia. Increasing evidence suggests RBD is a specific prodromal marker for synucleinopathy. In this symposium, discussing updated information on RBD from clinical and basic aspects will provide signficant implication for future disease modifying therapy targeting syncleinopathy.
○Masayuki Miyamoto1,2, Tomoyuki Miyamoto3 (1.Department of Clinical Medicine for Nursing, Dokkyo Medical University School of Nursing, Japan, 2.Center of Sleep Medicine, Dokkyo Medical University Hospital, Japan, 3.Department of Neurology, Dokkyo Medical University Saitama Medical Center)
○Yukiyoshi Sumi, Yuji Ozeki, Hiroshi Kadotani (Shiga University of Medical Science Department of Psychiatry, Japan)
○Hodaka Yamakado (Department of Neurology, Kyoto University Hospital, Japan)
○Hiroaki Fujita, Keisuke Suzuki (Dokkyo Medical University, Japan)